Kerala Daily

Open-Angle Glaucoma Market is Expected to Expand at a Healthy Growth Rate by 2030 | Key Companies – Allergan, SPARC Limited, Laboratorios Sophia, Nicox Ophthalmics, and Several Others

 Breaking News
  • No posts were found

Open-Angle Glaucoma Market is Expected to Expand at a Healthy Growth Rate by 2030 | Key Companies – Allergan, SPARC Limited, Laboratorios Sophia, Nicox Ophthalmics, and Several Others

October 13
04:25 2021
Open-Angle Glaucoma Market is Expected to Expand at a Healthy Growth Rate by 2030 | Key Companies - Allergan, SPARC Limited, Laboratorios Sophia, Nicox Ophthalmics, and Several Others
Delveinsight Business Research LLP
DelveInsight’s “Open-Angle Glaucoma Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Open-Angle Glaucoma Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Open-Angle Glaucoma market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2017 to 2030. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Open-Angle Glaucoma Market

Open-Angle Glaucoma: An Overview

Glaucoma describes a group of conditions in which there is characteristic cupping of the optic disc with corresponding visual field defects, due to retinal ganglion cell loss. It is a progressive condition and the most common cause of irreversible blindness worldwide. The two major categories of glaucoma are open-angle glaucoma (OAG) and narrow-angle glaucoma.

POAG is classified based on the age of onset, as primary congenital glaucoma (onset up to 3 years of age), juvenile open-angle glaucoma (JOAG; onset at 5–35 years), and adult-onset POAG (after the age of 35 years).

Open-Angle Glaucoma Market Key Facts

  • A recent review estimated the global number of Primary open-angle glaucoma (POAG) cases in 2013 at 44 million, rising to 53 million by 2020 due to population ageing.

  • Primary open-angle glaucoma (POAG) is the most common type of glaucoma accounting for three-quarters (74%) of all glaucoma cases.

  • As per DelveInsight, the total prevalent population of Glaucoma in the 7MM was around 10 million in 2018. In addition to this it was also assessed that among those with glaucoma in the 7MM, more than 8.5 million were diagnosed with OAG.

  • Females are affected more as compared to males, in the case of open-Angle  Glaucoma in the 7MM

Get FREE sample copy at: https://www.delveinsight.com/sample-request/open-angle-glaucoma-market

Key Benefits of Open-Angle Glaucoma Market Report

  • The report provides an in-depth analysis of Open-Angle Glaucoma Market Size and Share till 2030 in the seven major markets.

  • The report will help in developing business strategies by understanding the Open-Angle Glaucoma Market Trends, key players, and ongoing developments that shape and drive the market growth in the upcoming years.

  • It covers Open-Angle Glaucoma current treatment practices, emerging drugs, market share of the individual therapies in the 7MM.

  • The report provides a detailed assessment of the Open-Angle Glaucoma market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Open-Angle Glaucoma Market 

The Open-Angle Glaucoma market size is expected to increase during the study period owing to the expected launch of potential therapies, along with increasing awareness and development of new drug delivery systems to tackle non-adherence.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Open-Angle Glaucoma market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Open-Angle Glaucoma market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Open-Angle Glaucoma Epidemiology

The epidemiology section covers insights about the historical and current Open-Angle Glaucoma patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Open-Angle Glaucoma Epidemiology Segmentation

  • Total Diagnosed Prevalent Population of Open-Angle Glaucoma

  • Age-Specific Diagnosed prevalence of Open-Angle Glaucoma

  • Gender-Specific Diagnosed Prevalence of Open-Angle Glaucoma 

  • Type – Specific Diagnosed Prevalence of Open-Angle Glaucoma

Open-Angle Glaucoma Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Open-Angle Glaucoma market or expected to get launched in the market during the study period. The analysis covers Open-Angle Glaucoma market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Open-Angle Glaucoma Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

key companies in the Open-Angle Glaucoma Market include:

  • Allergan

  • SPARC Limited

  • Laboratorios Sophia 

  • Nicox Ophthalmics

And many others.

Open-Angle Glaucoma Therapies covered in the report includes:

  • Durysta (Bimatoprost SR)

  • PDP–716

  • PRO-122

  • DE-130A

And others.

Request for Sample @ Open-Angle Glaucoma Therapeutics Market Assessment

Table of Content

1. Key Insights

2. Executive Summary 

3. Open-Angle Glaucoma Competitive Intelligence Analysis

4. Open-Angle Glaucoma Market Overview at a Glance

5. Open-Angle Glaucoma Disease Background and Overview

6. Open-Angle Glaucoma Patient Journey

7. Open-Angle Glaucoma Epidemiology and Patient Population

8. Open-Angle Glaucoma Treatment Algorithm, Current Treatment, and Medical Practices

9. Open-Angle Glaucoma Unmet Needs

10. Key Endpoints of Open-Angle Glaucoma Treatment

11. Open-Angle Glaucoma Marketed Products

12. Open-Angle Glaucoma Emerging Therapies

13. Open-Angle Glaucoma Seven Major Market Analysis

14. Attribute Analysis

15. Open-Angle Glaucoma Market Outlook (7 major markets)

16. Open-Angle Glaucoma Access and Reimbursement Overview

17. KOL Views on the Open-Angle Glaucoma Market.

18. Open-Angle Glaucoma Market Drivers

19. Open-Angle Glaucoma Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at: https://www.delveinsight.com/sample-request/open-angle-glaucoma-market

Latest Reports By DelveInsight

Anaplastic Astrocytoma Market

DelveInsight’ s “Anaplastic Astrocytoma Market Insights, Epidemiology, and Market Forecast 2030” report provide a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology as well as the Anaplastic Astrocytoma market size, share, trends, and forecast for the seven major markets (i.e. the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Healthcare Blogs

Nutraceutical Market Size and Share Analysis

The global demand for Nutraceuticals as a nutritional product for good health & well-being and as a medicine has grown significantly over the past two to three decades. As per DelveInsight, the Nutraceuticals Market is expected to grow at a CAGR of 8.82% by 2026, owing to the rising demand and proactive participation by global companies in the segment. The key companies dominating the global Nutraceutical Market include Koninklijke, Fonterra, DuPont, Nemours, Ingredion Incorporated, ADM, Tate & Lyle, Cargill, and several others. Read More: Nutraceutical Market

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/